US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
EP1030652B1
(en)
*
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
PL193929B1
(pl)
|
1998-03-23 |
2007-04-30 |
Gen Mills Inc |
Jadalny produkt na bazie skrobi, kompozycja odżywcza oraz sposób wytwarzania jadalnego produktu
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
ATE275402T1
(de)
*
|
1999-11-01 |
2004-09-15 |
John Rhodes |
Arzneimittel zur behandlung von darmverstopfung und reizkolon
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
AU2001282064B2
(en)
*
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
CA2341952A1
(en)
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
WO2004050688A1
(en)
|
2002-12-02 |
2004-06-17 |
Xenome Ltd |
NOVEL χ-CONOTOXIN PEPTIDES (-II)
|
ATE547424T1
(de)
|
2002-12-02 |
2012-03-15 |
Xenome Ltd |
Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
|
DE602004030245D1
(de)
*
|
2003-07-03 |
2011-01-05 |
Sucampo Ag |
Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
|
RU2351315C2
(ru)
|
2003-07-24 |
2009-04-10 |
Смитклайн Бичам Корпорейшн |
Пленки, растворяющиеся в полости рта
|
EP1661574B1
(en)
*
|
2003-09-01 |
2017-04-19 |
Earthus, Inc. |
Beta-hydroxy short to medium chain fatty acid polymer
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
CA2571554A1
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
JP5254616B2
(ja)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
生物学的同調性(biosynchronous)経皮的薬物送達
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
WO2007041314A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
US20070078376A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Smith Gregory A |
Functionalized microneedles transdermal drug delivery systems, devices, and methods
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
CN104224823A
(zh)
|
2007-03-30 |
2014-12-24 |
有限会社爱泽世 |
生酮作用促进剂组合物
|
EP2322166A1
(en)
*
|
2007-04-02 |
2011-05-18 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
NZ582049A
(en)
*
|
2007-05-18 |
2012-12-21 |
Tti Ellebeau Inc |
Transdermal delivery devices assuring an improved release of an active principle through a biological interface
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
ES2676343T3
(es)
*
|
2010-12-21 |
2018-07-18 |
Fertin Pharma A/S |
Composición de goma de mascar que comprende ácido poliacrílico reticulado
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
CA2876540C
(en)
*
|
2012-06-15 |
2022-11-29 |
Conaris Research Institute Ag |
A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
|
CA2881158A1
(en)
|
2012-07-26 |
2014-01-30 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
HUE048488T2
(hu)
|
2013-12-13 |
2020-07-28 |
Conaris Res Institute Ag |
Nikotinsavat és/vagy nikotinamidot tartalmazó gyógyászati készítmény a vérlipid szint jótékony hatású befolyására történõ alkalmazásra a bélrendszeri mikrobióta módosításával
|
KR20160088436A
(ko)
|
2013-12-13 |
2016-07-25 |
코나리스 리써치 인스티튜트 아게 |
니코틴아미드 및 5-아미노살리실산의 조합을 포함하는, 장내 세균총에 유익한 영향을 미치거나 및/또는 위장 염증을 치료하기 위한 약학 조성물
|
EP3154530B1
(en)
|
2014-06-10 |
2018-04-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
WO2016145373A1
(en)
|
2015-03-12 |
2016-09-15 |
Chrono Therapeutics Inc. |
Craving input and support system
|
WO2017048566A1
(en)
*
|
2015-09-15 |
2017-03-23 |
C.B. Fleet Company, Incorporated |
Bisacodyl compositions and delivery apparatus
|
US10532046B2
(en)
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US20200085806A1
(en)
*
|
2016-12-20 |
2020-03-19 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
AU2018205529B2
(en)
|
2017-01-06 |
2023-08-10 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
JP7420797B2
(ja)
|
2018-05-29 |
2024-01-23 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
薬剤送達の方法及びシステム
|
CN112384504A
(zh)
|
2018-06-15 |
2021-02-19 |
R.J.雷诺兹烟草公司 |
烟碱的纯化
|